Company
Technology Platform
Products
Services
Resources
News & Events
Contact Us
More
News
August 17, 2021
NeuCyte and KIF1A.ORG Enter Collaboration Agreement
January 19, 2021
NeuCyte and Mount Sinai Enter Collaboration Agreement
September 25, 2019
NeuCyte and REPROCELL enter distribution agreement in North America and Europe
September 24, 2019
NeuCyte licenses promising novel compound for treatment of refractory epilepsy and related neurological disorders
December 3, 2018
NeuCyte outlicenses its novel neuronal programming technology
May 8, 2018
NeuCyte completes Series A financing
Events
September 27, 2022
NeuCyte exhibits at the Northern California Regional SOT Chapter Fall Symposium
March 27-30, 2022
NeuCyte exhibits and presents at Society of Toxicology annual meeting in San Diego, CA
September 16-18,2020
NeuCyte presents at Discovery on Target virtual conference
September 14-17, 2020
NeuCyte presents at Safety Pharmacology Society virtual meeting
August 27-28, 2020
NeuCyte presents at the Epilepsy Pipeline Conference virtual meeting
Sept. 29 - Oct. 3, 2019
NeuCyte presents at the International Neurotoxicity Association Meeting in Düsseldorf, Germany
September 23-26, 2019
NeuCyte exhibits at the Safety Pharmacology Society Annual Meeting
July 24-26, 2019
NeuCyte presents at the Precision Medicine Ion Channel Retreat
June 17-20, 2019
NeuCyte exhibits and presents at the World Preclinical in Boston, MA
March 10-14, 2019
NeuCyte exhibits and presents at the SOT (Society of Toxicology) Annual Meeting
